Best Acute Myeloid Leukemia Podcasts (2025)

1
Elena Elez, Barcelona, ASCO: BRAF Inhibitor Encorafenib Delays Progression, Extends Survival in Patients with Inoperable BRAF V600E Mutant Colorectal Cancer 15:34

Play Pause

5d ago15:34

15:34

An interview with: Elena Elez MD PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain CHICAGO, USA—Adding the BRAF inhibitor encorafenib (partnered with EGFR-inhibitor cetuximab) to standard chemotherapy as initial therapy markedly delayed progression and extended life in patients whose inoperable metastatic colorectal cancers had tested posi…

1
Yelena Janjigian ASCO Plenary: Peri-Operative Chemo-Immunotherapy Delays Recurrence in Patients with Gastric or GE Junction Cancers 4:49

7d ago4:49

4:49

An interview with: Yelena Y Janjigian MD, Medical Oncologist, Chief of Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York USA CHICAGO—A treatment described as “practice-changing”, in which a combination of anti-PD-L1 immunotherapy and chemotherapy was used before and after surgery among patients with resectable gast…

1
Christopher Booth MD: Post-Surgery Exercise Therapy Reduced Recurrence Risk and Extended Life in Patients with Colon Cancer 10:40

12d ago10:40

10:40

An interview with: Christopher Booth, MD, FRCPC Medical Oncologist and Professor, Queen’s University, Kingston, Canada Comments from: Rebecca Dent MD MSc, Senior Consultant Medical Oncologist, Deputy Chief Executive Officer, National Cancer Centre, Singapore CHICAGO— For patients with stage III and high-risk stage II colon cancer, a structured exer…

1
Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy 7:24

14d ago7:24

7:24

An interview with: Frank A Sinicrope, MD, Medical Oncologist, Mayo Clinic, Rochester, Minnesota. CHICAGO —Big gains in survival have been reported among patients with stage three, node-positive colon cancer whose tumors tested positive for deficient mismatch repair. At the American Society of Clinical Oncology 2025 Annual Meeting Frank Sinicrope re…

1
Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities 35:15

25d ago35:15

35:15

In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including: Key Comorbidit…

1
Single-cell RNA Sequencing Provides Comprehensive Map of Acute Myeloid Leukemia Cell States 15:01

1M ago15:01

15:01

An interview with: Andy Zeng, MD/PhD candidate, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada With comment from: Hussein A Abbas MD PhD, Assistant Professor, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston TX CHICAGO—A research study using single-cell RNA sequencing data has created a new …

1
Uncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications 21:54

1M ago21:54

21:54

In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, discuss the evolving safety considerations and future directions of HER2-targeted antibody–drug conjugates (ADCs) across genitourinary, gastrointestinal, and gynecologic cancers. Toxicity Profiles of HER2-Targeted ADCs: Common and…

1
Yelena Y Janjigian MD: PD-1 Blockade Directed by ctDNA Delayed Recurrence in Mismatch Repair Deficient Solid Tumors After Surgery and Standard of Care 9:47

1M ago9:47

9:47

An interview with: Yelena Y Janjigian MD, Medical Oncologist, Chief of Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York. CHICAGO, USA—Patients with early-stage solid cancers with DNA mismatch repair-deficiency (also known as microsatellite instability) benefitted greatly if they received anti-programmed death-1 (P…

1
Paolo Marchetti MD: Tissue or Liquid Biopsy? Both Together Could Be Best for Advanced Solid Tumor Therapy Planning 9:54

2M ago9:54

9:54

The Audio Journal of Oncology talks with: Paolo Marchetti MD, Scientific Director, Istituto Dermatopatico dell’Immacolata, Rome And with: Elaine R. Mardis, PhD FAACR, Co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital, Rasmussen Nationwide Foundation Endowed Chair in Genomic Medicin…

1
Patients with Relapsed or Refractory Acute Myeloid Leukemia have Remissions with “Logic Gated” Off-the-Shelf Natural Killer Cell Therapy 14:12

2M ago14:12

14:12

An Interview with: Stephen Strickland, Jr. MD MSCI, Director, Leukemia Research; Executive Chair, Leukemia Research Committee, Sarah Cannon Research Instiute, Nashville, Tennessee USA CHICAGO – Several patients with acute myeloid leukemia, who were treated with SENTI-202, a first-in-class chimeric antigen receptor (CAR) natural killer (NK) cell the…

1
More Breast Cancer Cases in Younger Women since 2010 But Fewer Deaths 14:50

2M ago14:50

14:50

An interview with: Adetunji T. Toriola, MD, PhD, MPH, Professor of Surgery, Department of Surgery and Division of Public Health Sciences, Washington University School of Medicine and Siteman Cancer Center, St Louis, Missouri, USA And with: Elaine R. Mardis, PhD FAACR, Co-executive director of the Steve and Cindy Rasmussen Institute for Genomic Medi…

1
Fast, Accurate Artificial Intelligence Method to Diagnose and Classify Pediatric Sarcoma Anywhere 15:56

2M ago15:56

15:56

An interview with: Adam Thiesen, PhD Candidate, UConn Health, University of Connecticut and the Jackson Laboratory for Genomic Medicine, Farmington, CT And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair, AACR Clinical Committee. CHICAGO – An artificial i…

1
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies 29:36

2M ago29:36

29:36

In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2-targeted antibody–drug conjugates (ADCs) and emerging clinical data with these agents across genitourinary, gastrointestinal, and gynecologic cancers. Mechanisms of action of ADCs: how ADCs selective…

1
EGFR-Sparing Anti-HER2 Drug Benefits Patients with Advanced HER2-Mutated Non-Small Cell Lung Cancer 12:59

2M ago12:59

12:59

An interview with: John V Heymach MD PhD, Professor and Chair of Thoracic/Head and Neck Medical Oncology, Ruth Legett Jones Distinguished Chair, University of Texas MD Anderson Cancer Center, Houston TX And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair,…

1
Neoadjuvant PD-1 Blockade Enables Patients with Mismatch Repair Deficient Colorectal Cancers to Avoid Surgery 14:03

2M ago14:03

14:03

An interview with: Andrea Cercek MD, Gastrointestinal Cancer Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York And: Ryan B Corcoran MD PhD, Director of the GI Cancer Program, Massachusetts General Hospital Cancer Center, Boston MA CHICAGO—The Audio Journal of Oncology reports on the neoadjuvant use of programmed cell-death protei…

1
Topical BRAF-inhibiting Gel Controls Acneiform Rash in Patients with Colorectal Cancer Treated with EGFR-inhibition 8:45

2M ago8:45

8:45

An interview with: Anisha B Patel MD, Associate Professor of Dermatology, Division of Internal Medicine, MD Anderson Cancer Center, Houston TX CHICAGO, USA—Acneiform rash toxicities caused by anti- epidermal growth factor receptor (EGFR) therapies were markedly reduced among patients with colorectal cancer in a double-blind placebo-controlled, rand…

1
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck Cancers 13:26

2M ago13:26

13:26

Interviews with: Ravindra Uppaluri, MD PhD, Director of Head and Neck Surgical Oncology, Dana Farber Brigham Cancer Center, Boston MA; And: Ryan B Corcoran MD PhD, Director of the gastrointestinal cancer program, Massachusetts General Hospital Cancer Center, Associate Professor of Medicine Harvard Medical School and Co-Chair of the American Associa…

1
RAS Inhibitor Zoldonrasib Brings Clinical Benefit in Patients with G12D Mutated Non-Small Cell Advanced Lung Cancer 12:15

2M ago12:15

12:15

An interview with: Kathryn C Arbour MD, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York USA And: Ryan B Corcoran MD PhD, Massachusetts General Cancer Center, Associate Professor of Medicine Harvard Medical School, Co-Chair, American Association for Cancer Research Clinical Trials Committee CHICAGO, USA— The four per ce…

1
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer 18:34

2M ago18:34

18:34

In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell lung cancer including: Rationale for targeting B7-H3 Overview of the structure of antibody-drug conjugates (ADCs) Results from the phase I/II IDeate-PanTumor01 trial of ifinatamab deruxtecan (I-…

1
Two Checkpoint Inhibitors in One Bispecific Molecule Improved Survival in Patients with High-Risk Gastric Cancer 10:10

2M ago10:10

10:10

An interview with: Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China Sarah Maxwell, Audio Journal of Oncology: The idea of harnessing two different pathways of checkpoint inhibition…

1
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies 14:09

2M ago14:09

14:09

In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alterations and the incidence of HER2-positive disease in the treatment of genitourinary, gastrointestinal, and gynecologic malignancies. HER2 Testing in Advanced Cancers: Recommendations for when and how …

1
Exosome Liquid Biopsy for Earliest Pancreatic Cancer Detection 13:10

2M ago13:10

13:10

An interview with: Ajay Goel PhD, Chair of the Molecular Diagnostics and Experimental Therapeutics Department, Beckman Research Institute, City of Hope, Los Angeles California. SAN DIEGO—The prospect of detecting pancreatic cancer at very early stages, when cure may be possible, is now being held out by research showing that the sub-cellular molecu…

1
Long Remissions with Bispecific T-cell Engager Antibody Therapy for Patients with Relapsed Multiple Myeloma 15:43

3M ago15:43

15:43

An interview with: Sundar Jagannath MBBS, Professor of Medicine, Hematology and Medical Oncology, Director of the Center of Excellence for Multiple Myeloma, Icahn School of Medicine, Mount Sinai, New York. Sarah Maxwell, Audio Journal of Oncology: “An exciting, new immunotherapy treatment for multiple myeloma, was under discussion at the 2024 Ameri…

1
Personalized Vaccine Brought Durable Immune Responses and Fewer Relapses in Head and Neck Cancers 13:33

3M ago13:33

13:33

An interview with: Olivier Lantz MD PhD, Head of the Clinical Immunology Laboratory, Institut Curie, Paris, France PARIS, France—A clinical trial using a personalized therapeutic vaccine, that recognizes multiple genetic features of each patient’s tumor, brought durable tumor-specific immune responses in patients with surgically resected HPV-negati…

1
Adding Anthracycline Improved Outcomes for Patients with High-Risk HR-positive, HER2-negative Breast Cancer 7:56

3M ago7:56

7:56

SAN ANTONIO, USA—Women with hormone receptor positive HER-2 negative breast cancer and Oncotype DX recurrence scores above 31 could benefit from having anthracycline therapy added to their taxane-based chemotherapy, according to breast medical oncologist and assistant professor of internal medicine, Nan Chen MD, from the University of Chicago. She …

1
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC 14:42

3M ago14:42

14:42

In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current treatment landscape for first-line treatment of patients with HER2-positive metastatic breast cancer including: Data from multicenter, single-arm, phase IIIb/IV DESTINY-Breast12 evaluating trastu…

1
Specific Subgroups of Patients with Metastatic Castration Resistant Prostate Cancer Live Longer with Talazoparib Added to their Enzalutamide Therapy 22:08

3M ago22:08

22:08

SAN FRANCISCO, CA—Adding the poly ADP ribose polymerase (PARP) inhibitor drug talazoparib to standard anti-androgen therapy with enzalutamide statistically significantly extended overall survival among patients whose metastatic castration resistant prostate cancers had specific molecular markers. This finding was reported at the 2025 American Socie…

1
Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab 13:37

3M ago13:37

13:37

Audio Journal of Oncology Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab LOS ANGELES, CA—Single agent immunotherapy with the anti-programmed death-1 (PD-1) agent pembrolizumab resulted in markedly high melanoma-specific survival rates among patients with either resectable or metastatic desmoplastic mel…

1
Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer 13:20

4M ago13:20

13:20

Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer The important question of whether to recommend risk-reducing surgery to patients who are carriers of pathogenic mutations in either BRCA1 or BRCA2 genes (or both), and have already developed breast cancer, has been i…

1
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer 45:08

4M ago45:08

45:08

In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions related to the CDK4/6 inhibitors used to treat patients with early and metastatic hormone receptor (HR)–positive/HER2-negative breast cancer from a live program held in January 2025. Key clinical p…

1
117: Exploring Apricot Seeds, Laetrile, and Reviving Natural Cancer Therapies | John A. Richardson, Jr. 51:46

4M ago51:46

51:46

John Richardson, Founder & Chief Visionary Officer of Operation World Without Cancer and Founder of Richardson Nutritional Center, passionately shares his family's advocacy for Laetrile, a natural cancer treatment derived from apricot seeds, and recounts powerful success stories in its application. The episode provokes critical questions about the …

1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting 20:01

4M ago20:01

20:01

In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…

1
116: Confronting Stage Four Prostate Cancer Through Faith and Holistic Healing | David and Kathi Peters 39:17

5M ago39:17

39:17

David and Kathy Peters share their journey following David's stage four prostate cancer diagnosis, focusing on their choice to pursue natural healing rather than conventional treatments. Highlighting the importance of community, diet, and emotional resilience, they encourage others to embrace holistic approaches to health. • David's prostate cancer…

1
115: Detoxification, Immune Therapies, and Environmental Toxins in Rising Young Adult Cancer | Dr. Tony Jimenez 34:02

5M ago34:02

34:02

This episode discusses the alarming rise of cancer in young adults, examining the environmental, dietary, and emotional factors involved. The conversation emphasizes holistic healing, the role of detoxification, and practical strategies for reducing health risks related to toxins and EMF exposure. • Discussion on increasing cancer rates among young…

1
E. Shelley Hwang MD MPH: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS 13:47

5M ago13:47

13:47

SAN ANTONIO, USA—In patients with hormone receptor-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS) active monitoring, compared with surgery, resulted in no difference in terms of cancer outcomes in the multicenter, randomized COMET study that compared oncologic outcomes of patients randomized to guideline-concordant care (with sur…

1
114: Healing Through Grief, Spiritual Growth, and Alternative Cancer Treatments | Jennifer Reiner 46:54

5M ago46:54

46:54

Jennifer Reiner shares her journey from personal loss and grief to healing and faith. Her experiences, including her nursing career and battles with cancer, reveal the profound link between emotional trauma and physical health, emphasizing holistic healing. • Exploring Jennifer's background in nursing and EMS • Impact of 9/11 on her personal and pr…

1
AUDIO JOURNAL OF ONCOLOGY: Safe to Spare Post-Mastectomy Chest Wall Radiotherapy in Most Patients with Intermediate Risk Breast Cancer 15:27

5M ago15:27

15:27

SAN ANTONIO, USA—There was no benefit from chest wall irradiation in patients who had intermediate-risk breast cancer, according to findings reported at the 2024 San Antonio Breast Cancer Symposium from the BIG 2-04 MRC SUPREMO international phase three randomized controlled trial. At the conference Ian Kunkler MA, MB, BChir, Professor at Edinburgh…

1
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer 36:04

6M ago36:04

36:04

In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium: Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast ca…

1
Jenny Paredes PhD, Duarte, CA: Increased Dietary Fiber Brings Longer Survival and Less GVHD After Allogeneic Stem Cell Transplantation 12:28

6M ago12:28

12:28

An interview with: Jenny Paredes PhD, of the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope National Medical Center in Duarte, California SAN DIEGO, USA—A higher intake of dietary fiber after allogeneic hematopoietic cell transplantation was associated with increased overall survival, a lower incidence of graft-vers…

1
113: Acute Myeloid Leukemia and Holistic Healing | Marlice Alves 36:19

6M ago36:19

36:19

Marlies Alves shares her journey from being a registered nurse to becoming a cancer patient, highlighting the importance of nutrition in overall health. She candidly discusses her experiences with acute myeloid leukemia, conventional cancer treatment, and how she found healing through holistic practices. • Growing up in Rhode Island after losing he…

1
Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia 13:07

6M ago13:07

13:07

SAN DIEGO, USA—When added to standard chemotherapy the bi-specific T-cell engager drug blinatumomab brought a large, statistically significant improvement in disease-free survival in a randomized controlled study of 1731 children with average or higher relapse-risk B-cell acute lymphoblastic leukemia. Study first author Rachel E. Rau MD, from the S…

1
112: Healing Advanced Cancer Through Holistic Approaches | Dr. Francisco Contreras 32:01

6M ago32:01

32:01

Dr. Francisco Contreras, Director of Oasis of Hope Hospital, shares his insights on maintaining miracles in cancer care. His holistic philosophy prioritizes non-harmful therapies and the power of diet. Move beyond the traditional and embrace the compassionate approach demonstrated by Oasis of Hope, which is inspired by medical principles like "firs…

1
111: Health Through Herbal Medicine, Brain Wellness and Being Prepared | Jane Barlow-Christensen 42:36

7M ago42:36

42:36

Learn about herbal medicine with Jane Barlow-Christensen, who has continued on her fathers mission, as she shares about the profound impact of plant remedies on brain health and overall wellness. Jane, a seasoned expert, shares her story of inheriting her father's legacy. Discover how natural remedies can contribute to your health as we highlight t…

1
Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia 7:26

7M ago7:26

7:26

Audio Journal of Oncology PodcastDecember, 2024: Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia Hua Zhang MD PhD (Chief Scientific Officer with SPH Biotherapeutics Limited, Shanghai and Hong Kong, China) tells the Audio Journal about the research findings he reported to the 2024 Annual Meeting o…

1
110: Diagnosis to Overcoming Non-Hodgkin Lymphoma | Benjamin Canales 31:42

7M ago31:42

31:42

Four year Idaho HealingStrong Group Leader, Benjamin Canales, shares his inspiring journey from his New York roots to overcoming cancer to now leading a free support group based in holistic health. In 2016, Ben received his cancer diagnosis, and described the initial symptoms. Ben also mentions the spiritual journey that emerged as an integral part…

1
109: Life After Grade 4 Brain Cancer with Humor and Hope | Jennifer Dickenson 34:46

7M ago34:46

34:46

Diagnosed in 2011 at the age of 44⁣, Jennifer Dickenson, a successful lawyer, shares her journey and transformation as a result of brain cancer. Jennifer received an official diagnosis of Glioblastoma Multiforme (grade 4 Brain Cancer) and in this interview, she covers the pressures of managing a large law firm during the financial crisis of 2007-20…

1
108: Overcoming Fear and Finding Purpose in Skating and Multiple Cancer Diagnoses pt2 | Scott Hamilton 29:27

7M ago29:27

29:27

This episode continues our conversation with Olympic gold medalist Scott Hamilton, who overcame childhood health challenges to achieving success in figure skating displays the value of resilience and perseverance. Scott shares his unique story as an adopted child, along with a humorous recollection of an early ice-skating mishap that nearly stopped…

1
107: Overcoming Fear and Finding Purpose in Skating and Multiple Cancer Diagnoses pt1 | Scott Hamilton 34:32

7M ago34:32

34:32

This episode features a conversation with Olympic gold medalist Scott Hamilton, who overcame childhood health challenges to achieving success in figure skating displays the value of resilience and perseverance. Scott shares his unique story as an adopted child, along with a humorous recollection of an early ice-skating mishap that nearly stopped hi…

1
106: PT.2 Overcoming Pancreatic Cancer with Faith, Community, and Holistic Healing | Kira Porter 31:58

8M ago31:58

31:58

Shakira Porter, who likes to be referred to as Kira and California HealingStrong Group Leader, faced an unexpected pancreatic cancer diagnosis at the age of 47, despite feeling like she led a seemingly healthy life. Kira continues her story of an urgent surgery and a challenging recovery. She candidly shares the unexpected moments, like finding iro…